MUC1-C INTEGRATES CHRONIC ACTIVATION OF INTERFERON PATHWAYS WITH CHROMATIN REMODELING IN TREATMENT RESISTANCE OF TRIPLE-NEGATIVE BREAST CANCER

被引：0
|
作者：
Yamashita, Nami
Morimoto, Yoshihiro
Fushimi, Atsushi
Ahmad, Rehan
Bhattacharya, Atrayee
Inoue, Yuka
Withers, Henry
Shapiro, Geoffrey
Yoshizumi, Tomoharu
Ueno, Takayuki
Ohno, Shinji
Long, Mark
Kufe, Donald
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-13-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-13-07
引用
收藏
页数：3
相关论文
共 50 条
  • [1] MUC1-C integrates chronic activation of the type I and II interferon pathways in treatment resistance of triple-negative breast cancer
    Yamashita, Nami
    Fushimi, Atsushi
    Morimoto, Yoshihiro
    Bhattacharya, Atrayee
    Long, Mark
    Liu, Song
    Kufe, Donald
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [2] MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells
    Yamamoto, Masaaki
    Jin, Caining
    Hata, Tsuyoshi
    Yasumizu, Yota
    Zhang, Yan
    Hong, Deli
    Maeda, Takahiro
    Miyo, Masaaki
    Hiraki, Masayuki
    Suzuki, Yozo
    Hinohara, Kunihiko
    Rajabi, Hasan
    Kufe, Donald
    CANCER RESEARCH, 2019, 79 (08) : 2031 - 2041
  • [3] MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer
    Hagiwara, Masayuki
    Fushimi, Atsushi
    Bhattacharya, Atrayee
    Yamashita, Nami
    Morimoto, Yoshihiro
    Oya, Mototsugu
    Withers, Henry G.
    Hu, Qiang
    Liu, Tao
    Liu, Song
    Wong, Kwok K.
    Long, Mark D.
    Kufe, Donald
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [4] MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
    Yamashita, Nami
    Long, Mark
    Fushimi, Atsushi
    Yamamoto, Masaaki
    Hata, Tsuyoshi
    Hagiwara, Masayuki
    Bhattacharya, Atrayee
    Hu, Qiang
    Wong, Kwok-Kin
    Liu, Song
    Kufe, Donald
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)
  • [5] Essential role for MUC1-C in chronic activation of cytosolic nucleotide sensing and the type I interferon pathway in triple-negative breast cancer
    Yamashita, Nami
    Fushimi, Atsushi
    Morimoto, Yoshihiro
    Bhattacharya, Atrayee
    Long, Mark
    Liu, Song
    Kufe, Donald
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer
    Yamashita, Nami
    Fushimi, Atsushi
    Morimoto, Yoshihiro
    Bhattacharya, Atrayee
    Hagiwara, Masayuki
    Yamamoto, Masaaki
    Hata, Tsuyoshi
    Shapiro, Geoffrey I.
    Long, Mark D.
    Liu, Song
    Kufe, Donald
    CANCERS, 2022, 14 (11)
  • [7] MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells
    Yamashita, Nami
    Withers, Henry
    Morimoto, Yoshihiro
    Bhattacharya, Atrayee
    Haratake, Naoki
    Daimon, Tatsuaki
    Fushimi, Atsushi
    Nakashoji, Ayako
    Thorner, Aaron R.
    Isenhart, Emily
    Rosario, Spencer
    Long, Mark D.
    Kufe, Donald
    ISCIENCE, 2023, 26 (11)
  • [8] MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
    Yamashita, Nami
    Morimoto, Yoshihiro
    Fushimi, Atsushi
    Ahmad, Rehan
    Bhattacharya, Atrayee
    Daimon, Tatsuaki
    Haratake, Naoki
    Inoue, Yuka
    Ishikawa, Satoshi
    Yamamoto, Masaaki
    Hata, Tsuyoshi
    Akiyoshi, Sayuri
    Hu, Qiang
    Liu, Tao
    Withers, Henry
    Liu, Song
    Shapiro, Geoffrey I.
    Yoshizumi, Tomoharu
    Long, Mark D.
    Kufe, Donald
    MOLECULAR CANCER RESEARCH, 2023, 21 (03) : 274 - 289
  • [9] Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression
    Yamashita, Nami
    Kufe, Donald
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [10] Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
    Hiraki, Masayuki
    Maeda, Takahiro
    Mehrotra, Neha
    Jin, Caining
    Alam, Maroof
    Bouillez, Audrey
    Hata, Tsuyoshi
    Tagde, Ashujit
    Keating, Amy
    Kharbanda, Surender
    Singh, Harpal
    Kufe, Donald
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2018, 3
12345